Articles in section Licensing
| << Joint Venture | 521 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 53 | Next >> |
-
Novartis Pays US$150 M Upfront for Monte Rosa’s Molecular Glue Degrader
-
Astellas Pays US$30 M Upfront for AviadoBio’s AAV-based Gene Therapy AVB-101
-
Sanofi Pays RadioMedix and Orano Med US$110 M Upfront for Radioligand Medicine
-
Roche Signs US$1.82 B Deal with Ascidian for RNA-Targeting Neurology Programmes
-
Vertex Signs License Agreement with Orum Therapeutics to Develop Novel Degrader-Antibody Conjugates for Conditioning Agents
-
AbbVie Signs US$1.7 B Pact with FutureGen for IBD Drug
-
Takeda Pays US$100 M Upfront for AC Immune’s Alzheimer’s Vaccine
-
Novo Nordisk Signs US$600 M Obesity Licensing Pact with Flagship’s Metaphore
-
Novartis Pays Arvinas US$150 M Upfront for Prostate Cancer Protein Degrader
-
Merck KGaA Signs Licensing Agreement with Abbisko for Pimicotinib
RSS